Implantation of cardioverter-defibrillator and cardiac resynchronization device in a patient with preserved right ventricular lead after tricuspid valve surgery

References (9)

1. Demir AD, Şen N, Erbay AR, Atak R. An effective and safe alternative to epicardial pacemaker placement for permanent pacemaker implantation in a patient with mechanical tricuspid valve: stimulation of the left ventricle through the coronary sinus. Türk Kardiyol Dern Arş 2011; 39: 244-7
2. McCarthy PM, Bhudia SK, Rajeswaran J, Hoercher KJ, Lytle BW, Cosgrove DM, et al. Tricuspid valve repair: durability and risk factors for failure. J Thorac Cardiovasc Surg 2004; 127: 674-85
3. Nakano K, Koyanagi H, Hashimoto A, Ohtsuka G, Nojiri C. Tricuspid valve replacement with the bileaflet St. Jude medical valve prosthesis. J Thorac Cardiovasc Surg 1994; 108: 888-92
4. Cleland JG, Daubert JC, Erdmann E, Freemantle N, Gras D, Kappenberger L, et al. The effect of cardiac resynchronization on morbidity and mortality in heart failure. N Engl J Med 2005; 352: 1539-49
5. Esperer HD, Mahmoud FO, von der Emde J. Is epicardial dual chamber pacing a realistic alternative to endocardial DDD pacing? Initial results of a prospective study. Clin Electrophysiol 1992; 15: 155-61
6. Laborde F, Mesnildrey P, Menasche P et al: Surgical alternative for ICD implantation. Clin Prog Electrophsiol Pacing 1986; 4: 31
7. Reynolds MR, Cohen DJ, Kugelmass AD, Brown PP, Becker ER, Culler SD, et al. The frequency and incremental cost of major complications among medicare beneficiaries receiving implantable cardioverter-defibrillators. J Am Coll Cardiol 2006; 47: 2493-7
8. Tummala RV, Riggio DR, Peters RW, Shorofsky SR, Gold MR. Chronic rise in defibrillation threshold with a hybrid lead system. Am J Cardiol 1996; 78: 309-12
9. Bardy GH, Smith WM, Hood MA, Crozier IG, Melton IC, Jordaens L, et al. An entirely subcutaneous implantable cardioverter–defibrillator. N Engl J Med 2010; 363: 36-44